Navigation Links
Alsius Corporation Announces Agreement to Sell Assets to ZOLL Medical Corporation
Date:2/20/2009

IRVINE, Calif., Feb. 20 /PRNewswire-FirstCall/ -. Alsius Corporation (Nasdaq: ALUS) announced today that it has signed an agreement with a wholly- owned subsidiary of ZOLL Medical Corporation (Nasdaq: ZOLL) under which Alsius will sell to ZOLL substantially all the assets constituting Alsius' intravascular temperature management device business for a purchase price of $12 million in cash. The assets to be acquired include the intellectual property relating to the business, other intangibles, inventories and fixed assets. The closing of the transaction is subject to customary closing conditions.

Leerink Swann LLC acted as exclusive financial advisor and delivered an opinion to the board of Alsius as to the fairness of the transaction.

William Worthen, Alsius' President and Chief Executive Officer, stated, "As we considered various options for Alsius in today's tough financing and capital spending environment, we determined that the sale to ZOLL is in the best interests of our stockholders, and a positive result for our customers and the patients who need our products. ZOLL's significant investment in and knowledge of critical care hospital products and considerable financial strength will serve to ensure that Alsius' solutions for temperature management continue to be provided and supported."

The transaction has been approved by holders of a majority of Alsius' outstanding stock pursuant to a written consent in accordance with Section 228 of the Delaware General Corporation Law and Alsius' bylaws. Alsius intends to prepare an information statement that will be filed with the SEC and disseminated to all Alsius stockholders to report in detail on the terms and provisions of the transaction and the winding
'/>"/>

SOURCE Alsius Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Alsius Corporation to Host Third Quarter 2007 Financial Results Conference Call/Webcast on November 13, 2007
2. Alsius Corporation Announces Program for Early Exercise of Warrants
3. Alsius Corporation Reports Record Fourth Quarter and Full Year 2007 Financial Results
4. Alsius Corporation Receives Regulatory Approval in China and Mexico
5. Alsius Corporation Awarded Three-Year Agreement With MedAssets Supply Chain Systems
6. Alsius Corporation Awarded Three-Year Agreement with HealthTrust Purchasing Group
7. Alsius Corporation Awarded Three-Year Agreement With Premier, Inc.
8. Alsius Corporation to Host Third Quarter 2008 Financial Results Conference Call on November 6
9. Alsius Corporation Reports Record Third Quarter 2008 Financial Results and Business Progress
10. Alsius Corporation Pre-Announces Record Fourth Quarter and Full Year 2008 Revenue
11. ALSIUS CORPORATION PREPARED TO INVALIDATE ZOLL TEMPERATURE MANAGEMENT PATENTS

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...HINGTON, Nov. 8 Speaker...conference following the House passage of H.R. 396...e bill passed by a vote of 220 to 215. Below are ...of my colleagues just received a call from the Pre...ulating us on a great victory for the American peo...
(Date:11/8/2009)...HINGTON, Nov. 7 Tonight...e Health Care for America Act, landmark health ref...s access to quality, affordable, stable and secure...ks down on some of the insurance industry,s worst ...ricans and cut the deficit by $104 billion over te...
(Date:11/8/2009)... New book called "Preventing ...by Dr. Roberto Giraldo shows that AIDS is a result...ariety of so-called immune system stressor agents,...al and most of all, emotional. , ...rom Nov. 6 – 8, 2009, cell biologists, physi...
(Date:11/8/2009)... 3D Global Solutions is pleased to...anaging the proposal effort for ReSound who recent...l Hearing Aid contract. The award includes not onl...ment of Defense and other federal agencies. , ... 8, 2009 -- 3D Global Solutions is pleased to anno...
(Date:11/8/2009)... Freeze-drying of biopharmaceutica...uga, Ontario facility. , ...llner, President and CEO of Therapure Biopharma In...very of a commercial scale pharmaceutical grade fr...eeze drying (lyophilization) available for contrac...
Breaking Medicine News(10 mins):Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 2Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 3Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 3Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 3Health News:Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer 2
... COLUMBUS , Ohio The chronic stress that spouses... disease patients may shorten the caregivers, live...uggests. , The research also provides concrete e...ed this month by researchers from Ohio State Unive...
...NION CITY, Calif., Sept. 18 Abaxis, Inc.,(Nasdaq:... point-of-care,blood analysis systems, announced t...present at the 2007 UBS Global Life Science Confer... presentation at, http://www.ibb.ubs.com . Click o...
... PHILADELPHIA − Human white blood cells, en..., could provide a novel therapy for patients with ...lastic leukemia (ALL), according to researchers at...s human B cells, the researchers were able to erad...
...OUNTAIN VIEW, Calif., Sept. 18 Pharsight,Corporat... of software and,strategic services for optimizing...t has filed an application to list its common stoc...r Pharsight," said Shawn,O,Connor, president, CEO,...
...assportMD Offers Safe, Secure & Free Personal Heal...t. 18 News that radio frequency,identification (R... even,cancer -- has the healthcare and personal he...nd non-invasive alternative already exists. Consum...
...onsumers Urged To Use Online Quality Information B...spital, MINNEAPOLIS, Sept. 18 The Leapfrog Group...oday released this year,s results from a,comprehen...rens, Hospitals and Clinics in Minneapolis and St....
Other Medicine News:Health News:Chronic stress can steal years from caregivers' lifetimes 2Health News:Chronic stress can steal years from caregivers' lifetimes 3Health News:Abaxis to Present at the 2007 UBS Global Life Science Conference 2Health News:T vs. B: Re-engineered human T cells effectively target and kill cancerous B cells 2Health News:T vs. B: Re-engineered human T cells effectively target and kill cancerous B cells 3Health News:Pharsight Files Application for Nasdaq Capital Market Listing 2Health News:Pharsight Files Application for Nasdaq Capital Market Listing 3Health News:RFID Implant Cancer Questions Concern Patients 2Health News:Four Minnesota Hospitals Rate High For Patient Safety and Quality 2
(Date:11/6/2009)...ll/ -- Oxygen Biotherapeutics, Inc. (OTC Bulletin ...roved reverse split of its common stock will take ...2009 on a 1-for-15 split-adjusted basis. Oxygen Bi...w symbol OXBT. The stock also will have a new CUSI...ctive. ,, "This reverse split was overwhelmingl...
(Date:11/6/2009)...PRNewswire/ -- In consultation with the U.S. Food ...lthcare, Division of McNEIL-PPC, Inc., is initiati...ct lots of TYLENOL® Arthritis Pain Caplet 100...AP. McNeil is initiating the recall after identify...with these lots that led to a small number of cons...
(Date:11/6/2009)...Therapeutics, Inc. announced today that it has fil....S. Securities and Exchange Commission (SEC) relat...s of its common stock. All shares of the common st...the Company. ,, Credit Suisse Securities (USA) ...Jaffray & Co. is acting as co-lead manager and...
Breaking Medicine Technology:Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 2Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 3McNeil Consumer Healthcare Announces Voluntary Recall of Certain Lots of TYLENOL(R) Arthritis Pain 100 Count with EZ-OPEN CAP 2Video 3A New Insights Link Low HDL Cholesterol and Elevated Triglycerides with Coronary Heart Disease and Microvascular Complications in Patients at G 55865 1Video 3A New Insights Link Low HDL Cholesterol and Elevated Triglycerides with Coronary Heart Disease and Microvascular Complications in Patients at G 55865 2Video 3A New Insights Link Low HDL Cholesterol and Elevated Triglycerides with Coronary Heart Disease and Microvascular Complications in Patients at G 55865 3Video 3A New Insights Link Low HDL Cholesterol and Elevated Triglycerides with Coronary Heart Disease and Microvascular Complications in Patients at G 55865 4Video 3A New Insights Link Low HDL Cholesterol and Elevated Triglycerides with Coronary Heart Disease and Microvascular Complications in Patients at G 55865 5Video 3A New Insights Link Low HDL Cholesterol and Elevated Triglycerides with Coronary Heart Disease and Microvascular Complications in Patients at G 55865 6Video 3A New Insights Link Low HDL Cholesterol and Elevated Triglycerides with Coronary Heart Disease and Microvascular Complications in Patients at G 55865 7Video 3A New Insights Link Low HDL Cholesterol and Elevated Triglycerides with Coronary Heart Disease and Microvascular Complications in Patients at G 55865 8SIGVARIS USA Extends Educational Efforts in Healthy Advices Skin Care Network 55860 1SIGVARIS USA Extends Educational Efforts in Healthy Advices Skin Care Network 55860 2SIGVARIS USA Extends Educational Efforts in Healthy Advices Skin Care Network 55860 3New Medical Technology Company CareFusion Spins Off From Cardinal Health Begins Trading on NYSE 55856 1New Medical Technology Company CareFusion Spins Off From Cardinal Health Begins Trading on NYSE 55856 2
...ating to Company Oncology Programs to be Presented...ewswire-FirstCall/ -- Cytokinetics, Incorporated a...inical data will be,presented at the 2007 Annual M...arch (AACR) to be held from April 14- 18, 2007 in,...iple oncology,programs at Cytokinetics and will pr...
...(BUSINESS WIRE)--Apr 10, 2007 - Inotek,Pharmaceuti...n the,journal Stroke of preclinical animal data sh...) polymerase (PARP) inhibitor,has a large protecti...ollowing a stroke. PARP is a nuclear enzyme that d...n and recruitment of DNA,repair enzymes and has po...
Other Medicine Technology:Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 2Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 3Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 4Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 5Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 6Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 7Inotek Pharmaceuticals Announces Publication of Animal Data from,Study of PARP Inhibition as Potential Preventative of Brain Injury,Following Stroke 2Inotek Pharmaceuticals Announces Publication of Animal Data from,Study of PARP Inhibition as Potential Preventative of Brain Injury,Following Stroke 3
...g; and Zyplast® injectable collagen implants h...hing facial lines, wrinkles and scars and in provi...the skins natural collagen, require minimal proced...re than one million people worldwide have been tre...
Captique™ Hyaluronic Acid Dermal Filler
...ge of non-surgical facial contouring materials. Yo... results for various applications with exceptional...fers superior versatility for a wide variety of no... Long-lasting, Radiesse saves time and money for b...
HEMOCHRON Model 401 Coagulation Monitoring Instrument
Medicine Products: